Industries > Pharma > Global Live Vaccines Market Forecast 2020-2030

Global Live Vaccines Market Forecast 2020-2030

Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others PLUS analysis on leading companies in the Live Vaccines Market

PUBLISHED: 12 March 2020
PAGES: 213
PRODUCT CODE: PHA0725
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

covid-19

The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.

The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Live Vaccines Market from 2020-2030

Global Live Vaccines Market Forecast 2020-2030

• Forecast of the Global Live Vaccines Market by Type of Product:
• Bacterial
• Viral

• Forecast of the Global Live Vaccines Market by Indication:
• Oral Polio Vaccine (OPV)
• Measles
• Rotavirus
• Tuberculosis
• Yellow Fever
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Canada
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Brazil
• Mexico

• Our study discusses the selected leading companies that are the major players in the live vaccines market:
• AstraZeneca
• Bavarian Nordic A/S
• DAIICHI SANKYO COMPANY, LIMITED
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Inovio Pharmaceuticals, Inc.
• & Other Companies

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the SWOT & PEST Analyses of the live vaccines market.

Visiongain’s study is intended for anyone requiring commercial analyses for the live vaccines market. You find data, trends and predictions.

Buy our report today Global Live Vaccines Market Forecast 2020-2030: Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Live Vaccines Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category